Article
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma.
Brain tumor pathology - 1 Jul 2021
Adachi Jun-Ichi, Shirahata Mitsuaki, Suzuki Tomonari, Mishima Kazuhiko, Uchida Eita, Sasaki Atsushi, Nishikawa Ryo
Abstract excerpt
Two hot spot mutations (C228T, C250T) in the telomerase reverse transcriptase (TERT) gene are frequently identified in glioblastoma and oligodendroglioma. TERT mutations predicts an aggressive clinical course in isocitrate dehydrogenase (IDH) wild-type astrocytic tumors. Therefore, it is important to accurately detect TERT promoter mutations in glioma. Sanger DNA sequencing is the currently standard method for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
